U.S. generic drug prices are 33% lower than international peers, while brand-name drugs cost nearly triple. Discover how rebates, competition, and Medicare negotiation shape this complex pricing landscape.
Read More
Explore how pharmaceutical companies use authorized generics to maintain revenue and fight competition after patent expiration, including their impact on drug prices.
Read More
Learn how consumer protection laws shield patients from predatory medical billing, the No Surprises Act, and new regulations on medical debt and consent.
Read More© 2026. All rights reserved.